Royalty Pharma
RPRX
#623
Rank
S$50.94 B
Marketcap
S$88.60
Share price
-0.01%
Change (1 day)
72.58%
Change (1 year)

Royalty Pharma (RPRX) - Cash on Hand

Cash on Hand as of June 2026 : S$2.22 Billion

According to Royalty Pharma's latest financial reports the company has S$2.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Royalty Pharma - Cash on Hand chart (from 2019 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$1.91 B-20.43%
2024-12-31S$2.40 B47.74%
2023-12-31S$1.62 B-49.94%
2022-12-31S$3.25 B-14.12%
2021-12-31S$3.78 B8.14%
2020-12-31S$3.50 B227.72%
2019-12-31S$1.06 B-67.19%
2018-12-31S$3.25 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Abbott Laboratories
ABT
S$9.41 B 322.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$6.30 B 182.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$0.48 B-78.23%๐Ÿ‡บ๐Ÿ‡ธ USA